Paul Hudson (businessman) explained

Paul Hudson
Birth Date:14 October 1967
Nationality:British
Education:Manchester Metropolitan University
CEO, Sanofi
Term:September 2019-
Predecessor:Olivier Brandicourt
Children:3

Paul Hudson (born 14 October 1967)[1] is a British businessman, and the chief executive (CEO) of Sanofi, the world's fifth largest pharmaceutical company by prescription drug sales.[2]

Early life

Hudson earned a degree in economics from Manchester Metropolitan University, and a diploma in marketing from the Chartered Institute of Marketing.[3]

Career

Hudson has been CEO of Sanofi since September 2019.[4] [5] [6]

Hudson was previously CEO of Novartis Pharmaceuticals, and before that AstraZeneca, rising to president, AstraZeneca United States and Executive Vice President, North America.[6] [7] [8]

Recognition

Hudson was awarded an honorary doctorate by Manchester Metropolitan University in 2018.[3] [9]

Personal life

Hudson has three children with his wife Sandra and is an "ardent Manchester United football fan".[3]

Notes and References

  1. Web site: Paul Hudson - Sanofi . www.sanofi.com . 29 January 2021 . en.
  2. Web site: French self-esteem hit after Pasteur Institute abandons Covid vaccine. Kim. Willsher. January 26, 2021. www.theguardian.com.
  3. Web site: Paul Hudson - Sanofi. www.sanofi.com.
  4. Web site: Sanofi CEO sees Big Pharma collaborating more even after a COVID vaccine is approved. Fortune.
  5. Web site: Sanofi's CEO on a big acquisition, long-term strategy, and vaccines. August 17, 2020.
  6. Web site: Global Proof of Concept: Q&A with Paul Hudson | Thought Leadership. Russell Reynolds Associates. 26 January 2021. 24 February 2021. https://web.archive.org/web/20210224234354/https://www.russellreynolds.com/insights/thought-leadership/global-proof-concept-q-and-a-paul-hudson. dead.
  7. News: AstraZeneca announces changes to Senior Executive Team . Fiercepharma .
  8. Web site: Novartis focuses Pharmaceuticals Division by creating two business units, Novartis Pharmaceuticals and Novartis Oncology; appoints leaders to the Executive Committee of Novartis . 2023-04-24 . Novartis . en.
  9. Web site: Paul Hudson . 2023-04-24 . Manchester Metropolitan University . en.